The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review
Authors:
- 31 August 2022
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 57, 152088
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literatureImmunologic Research, 2013
- Short‐term and long‐term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patientsArthritis & Rheumatism, 2011
- Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositisBMC Musculoskeletal Disorders, 2010
- Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositisRheumatology, 2010
- RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung diseaseArthritis & Rheumatism, 2009
- Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/DermatomyositisLung, 2009
- Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiologyArthritis Care & Research, 2008
- Unusually high frequency of autoantibodies to PL‐7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositisArthritis & Rheumatism, 2006
- Interstitial lung disease in polymyositis and dermatomyositisArthritis Care & Research, 2002
- Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and DermatomyositisNew England Journal of Medicine, 1992